Literature DB >> 29523593

Evaluation of Potential Living Kidney Donors in the APOL1 Era.

Barry I Freedman1, Bruce A Julian2.   

Abstract

Entities:  

Keywords:  APOL1; African American; chronic kidney disease; kidney donation; safety; transplantation

Mesh：

Substances：

Year:  2018        PMID： 29523593      PMCID： PMC5875967          DOI： 10.1681/ASN.2018020137

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  10 in total

1.  Association of trypanolytic ApoL1 variants with kidney disease in African Americans.

Authors:  Giulio Genovese; David J Friedman; Michael D Ross; Laurence Lecordier; Pierrick Uzureau; Barry I Freedman; Donald W Bowden; Carl D Langefeld; Taras K Oleksyk; Andrea L Uscinski Knob; Andrea J Bernhardy; Pamela J Hicks; George W Nelson; Benoit Vanhollebeke; Cheryl A Winkler; Jeffrey B Kopp; Etienne Pays; Martin R Pollak
Journal:  Science       Date:  2010-07-15       Impact factor: 47.728

2.  The APOL1 gene and allograft survival after kidney transplantation.

Authors:  A M Reeves-Daniel; J A DePalma; A J Bleyer; M V Rocco; M Murea; P L Adams; C D Langefeld; D W Bowden; P J Hicks; R J Stratta; J-J Lin; D F Kiger; M D Gautreaux; J Divers; B I Freedman
Journal:  Am J Transplant       Date:  2011-04-12       Impact factor: 8.086

3.  APOL1 Genotype and Renal Function of Black Living Donors.

Authors:  Mona D Doshi; Mariella Ortigosa-Goggins; Amit X Garg; Lihua Li; Emilio D Poggio; Cheryl A Winkler; Jeffrey B Kopp
Journal:  J Am Soc Nephrol       Date:  2018-01-16       Impact factor: 10.121

Review 4.  Gene-gene and gene-environment interactions in apolipoprotein L1 gene-associated nephropathy.

Authors:  Barry I Freedman; Karl Skorecki
Journal:  Clin J Am Soc Nephrol       Date:  2014-06-05       Impact factor: 8.237

5.  The APOL1 genotype of African American kidney transplant recipients does not impact 5-year allograft survival.

Authors:  B T Lee; V Kumar; T A Williams; R Abdi; A Bernhardy; C Dyer; S Conte; G Genovese; M D Ross; D J Friedman; R Gaston; E Milford; M R Pollak; A Chandraker
Journal:  Am J Transplant       Date:  2012-04-04       Impact factor: 8.086

Review 6.  Apolipoprotein L1 Gene Effects on Kidney Transplantation.

Authors:  Barry I Freedman; Jayme E Locke; Amber M Reeves-Daniel; Bruce A Julian
Journal:  Semin Nephrol       Date:  2017-11       Impact factor: 5.299

7.  APOL1 polymorphisms and development of CKD in an identical twin donor and recipient pair.

Authors:  Tomek Kofman; Vincent Audard; Céline Narjoz; Olivier Gribouval; Marie Matignon; Claire Leibler; Dominique Desvaux; Philippe Lang; Philippe Grimbert
Journal:  Am J Kidney Dis       Date:  2014-02-08       Impact factor: 8.860

8.  APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors.

Authors:  Barry I Freedman; Stephen O Pastan; Ajay K Israni; David Schladt; Bruce A Julian; Michael D Gautreaux; Vera Hauptfeld; Robert A Bray; Howard M Gebel; Allan D Kirk; Robert S Gaston; Jeffrey Rogers; Alan C Farney; Giuseppe Orlando; Robert J Stratta; Sumit Mohan; Lijun Ma; Carl D Langefeld; Donald W Bowden; Pamela J Hicks; Nicholette D Palmer; Amudha Palanisamy; Amber M Reeves-Daniel; W Mark Brown; Jasmin Divers
Journal:  Transplantation       Date:  2016-01       Impact factor: 4.939

9.  Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate.

Authors:  Morgan E Grams; Yingying Sang; Andrew S Levey; Kunihiro Matsushita; Shoshana Ballew; Alex R Chang; Eric K H Chow; Bertram L Kasiske; Csaba P Kovesdy; Girish N Nadkarni; Varda Shalev; Dorry L Segev; Josef Coresh; Krista L Lentine; Amit X Garg
Journal:  N Engl J Med       Date:  2015-11-06       Impact factor: 91.245

10.  Apolipoprotein L1 and Chronic Kidney Disease Risk in Young Potential Living Kidney Donors.

Authors:  Jayme E Locke; Deirdre Sawinski; Rhiannon D Reed; Brittany Shelton; Paul A MacLennan; Vineeta Kumar; Shikha Mehta; Roslyn B Mannon; Robert Gaston; Bruce A Julian; John J Carr; James G Terry; Meredith Kilgore; Allan B Massie; Dorry L Segev; Cora E Lewis
Journal:  Ann Surg       Date:  2018-06       Impact factor: 13.787
  10 in total
  4 in total

Review 1.  Practical Considerations for APOL1 Genotyping in the Living Kidney Donor Evaluation.

Authors:  Alejandra M Mena-Gutierrez; Amber M Reeves-Daniel; Colleen L Jay; Barry I Freedman
Journal:  Transplantation       Date:  2020-01       Impact factor: 4.939

2.  Opinions of African American adults about the use of apolipoprotein L1 (ApoL1) genetic testing in living kidney donation and transplantation.

Authors:  Margaret Berrigan; Jasmine Austrie; Aaron Fleishman; Kenneth P Tercyak; Martin R Pollak; Martha Pavlakis; Vinayak Rohan; Prabhakar K Baliga; Liise K Kayler; Thomas H Feeley; James R Rodrigue
Journal:  Am J Transplant       Date:  2020-08-29       Impact factor: 8.086

3.  Apolipoprotein L1: role in the evaluation of kidney transplant donors.

Authors:  Krista L Lentine; Roslyn B Mannon
Journal:  Curr Opin Nephrol Hypertens       Date:  2020-11       Impact factor: 3.416

Review 4.  Digital pathology and computational image analysis in nephropathology.

Authors:  Laura Barisoni; Kyle J Lafata; Stephen M Hewitt; Anant Madabhushi; Ulysses G J Balis
Journal:  Nat Rev Nephrol       Date:  2020-08-26       Impact factor: 28.314
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.